Early research (Phase 1)Looking for participantsNCT05316129
What this trial is testing
Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer
Who this might be right for
Ovarian Cancer
H. Lee Moffitt Cancer Center and Research Institute 10